Directory
Portfolio companies.
34,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
54
currently held
Exits tracked
51
hand-checked
Sectors covered
1
across the portfolio
Countries covered
1
from every market
Latest activity
Capital Event · capital-cancellation-shares · Capital structure change
capitalCapital Event · capital-cancellation-shares · Capital structure change
capitalCapital Event · capital-cancellation-shares · Capital structure change
capitalCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway
adminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board
admin75 companies matching · Page 2 of 2
H2 Pharma
Ardian Growth Fund II
Sector
Pharma
InvestorArdian
Entry
2020
Hold
6yr
Horus Pharma
Nov Sante Actions Non Cotees
Sector
Pharma
InvestorEurazeo
Entry
2022
Hold
4yr
Interor
Capital Santé 2
Sector
Pharma
InvestorTurenne Groupe
Entry
2020
Hold
6yr
Laboratoire Polidis
Siparex Entrepreneurs 6
Sector
Pharma
InvestorSiparex
Entry
2025
Hold
1yr
MAYOLY SPINDLER
CAPZA Flex Equity Mid-Market I
Sector
Pharma
InvestorCapza
Entry
2022
Hold
4yr
Meribel Pharma
Ardian Buyout Fund VII
Sector
Pharma
InvestorArdian
Entry
2020
Hold
6yr
MITEM Pharma
TechLife Capital I
Sector
Pharma
InvestorTechLife Capital
Entry
2020
Hold
6yr
Pharmatis
Fonds Franco-Africain II (FFA2)
Sector
Pharma
InvestorAfricinvest Europe
Entry
2024
Hold
2yr
POC Pharma
Alven V
Sector
Pharma
InvestorAlven
Entry
2024
Hold
2yr
Septodont
CIC Debt Fund 4
Sector
Pharma
InvestorCIC Private Debt
Entry
2023
Hold
3yr
SFAN Laboratoire
Vivalto Partners Fund I
Sector
Pharma
InvestorVivalto Partners
Entry
2025
Hold
1yr
Skyepharma
Jadel Evergreen
Sector
Pharma
InvestorJadel
Entry
2021
Hold
5yr
Swixx
Stags Participations
Sector
Pharma
InvestorStags Participations
Entry
2020
Hold
6yr
THX Pharma
Odyssee Venture Funds
Sector
Pharma
InvestorOdyssée Venture
Entry
2025
Hold
1yr
Verretubex
FPCI Capitem 1
Sector
Pharma
InvestorCapitem Partenaires
Entry
2014
Hold
12yr
Nuclidium
Wellington Partners Life Sciences
Sector
Pharma
InvestorWellington Partners
Entry
2025
Hold
1yr
Owners
5
Delpharm
IDIA Small & Midcap
Sector
Pharma
InvestorIdia
Entry
2007
Hold
5yr
Owners
4
Medincell
Crédit Mutuel Equity
Sector
Pharma
InvestorCrédit Mutuel Equity
Entry
2017
Hold
9yr
Owners
3
Sagitta Pharma
Acto V
Sector
Pharma
InvestorAndera Partners
Entry
2021
Hold
5yr
Owners
2
Ceva II
IXO 5
Sector
Pharma
InvestoriXO Private Equity
Entry
2025
Hold
1yr
Cooperation Pharmaceutique
CM-CIC Debt Fund 3
Sector
Pharma
InvestorCIC Private Debt
Entry
2021
Hold
5yr
Crossject
Vatel Flexible
Sector
Pharma
InvestorVATEL CAPITAL
Entry
2025
Hold
1yr
Oralance Pharma
CapDecisif 3
Sector
Pharma
InvestorKarista
Entry
2008
Hold
18yr
Pharmactive
Siparex Midcap 4
Sector
Pharma
InvestorSiparex
Entry
2021
Hold
5yr
PHERECYDES PHARMA
Loire Valley Invest
Sector
Pharma
InvestorGo Capital
Entry
2018
Hold
8yr